ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $321,000 | +121.4% | 22,813 | +280.0% | 0.01% | +140.0% |
| Q1 2022 | $145,000 | +705.6% | 6,003 | +664.7% | 0.01% | +400.0% |
| Q4 2021 | $18,000 | -86.0% | 785 | -89.9% | 0.00% | -75.0% |
| Q3 2021 | $129,000 | -44.2% | 7,747 | -18.3% | 0.00% | -42.9% |
| Q2 2021 | $231,000 | +11.6% | 9,488 | +18.1% | 0.01% | 0.0% |
| Q1 2021 | $207,000 | -67.2% | 8,033 | -38.3% | 0.01% | -90.0% |
| Q2 2020 | $631,000 | +4753.8% | 13,026 | +4315.6% | 0.07% | +2233.3% |
| Q4 2019 | $13,000 | -76.4% | 295 | -91.8% | 0.00% | -84.2% |
| Q2 2018 | $55,000 | -45.0% | 3,591 | -19.1% | 0.02% | -63.5% |
| Q1 2018 | $100,000 | +614.3% | 4,439 | +822.9% | 0.05% | +372.7% |
| Q4 2017 | $14,000 | +600.0% | 481 | +862.0% | 0.01% | +1000.0% |
| Q3 2017 | $2,000 | -90.5% | 50 | -91.9% | 0.00% | -96.3% |
| Q1 2017 | $21,000 | -40.0% | 619 | -49.4% | 0.03% | -22.9% |
| Q4 2016 | $35,000 | – | 1,223 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |